Amid the rising prevalence of cancer worldwide, significant strides have been made in the cancer diagnostics market to improve treatment outcomes and survival rates. According to Roots Analysis, the ...

Should you invest in stocks right now? Some might be hesitant to do so because of the volatility broader equities have faced ...

Dr Joshua Nass, of the Michigan Institute for Neurological Disorders, discussed the 10 most common signs of ailing health ...

There is sufficient blood in stock for those injured in the Uttara plane crash, said Prof Dr Sayedur Rahman, Special ...

Milwaukee County is using more opioid settlement funds for treatment, hoping to continue trends of lower overdoses in the ...

Poor-quality or unregulated caviar also carries a risk of heavy metal or pollutant contamination; however, Gentry notes that ...

Johnson & Johnson reported second-quarter results on July 16. Sales of pharmaceuticals have been muted due to a loss of ...

Pfizer (NYSE: PFE) was on top of the world when it came to earnings and stock price performance. This was in early pandemic ...

This research aims to develop a more accurate and efficient system for classifying skin diseases, including both malignant and non-cancerous conditions. The study utilizes a comprehensive dataset ...

Mexican President Claudia Sheinbaum said Mexico will step up efforts to obtain preferential tariff treatment from the Trump administration, particularly in the automotive sector where both ...

Investing.com - UBS has reiterated its Neutral rating and $170.00 price target on Zoetis Inc . (NYSE: ZTS), a company maintaining a robust 71% gross profit margin, following FDA approval of Merck (NSE ...

This agreement includes potential milestone payments and royalties on net sales. Furthermore, H.C. Wainwright has maintained its Buy rating on Lipocine, emphasizing the potential of LPCN 1154 to ...